AbCellera Biologics Inc. Common Shares Stock Prediction
AI-powered sentiment analysis and prediction trends for ABCL, updated each market day.
ABCL AI Sentiment
AI predicts AbCellera Biologics Inc. Common Shares stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About AbCellera Biologics Inc. Common Shares
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications. ABCL635, ABCL386, ABCL575, and ABCL635.
Sector
Exchange
Market Cap
$1,042,872,075
Cap Tier
Employees
562
Headquarters
VANCOUVER, A1
Listed Since
Dec. 11, 2020
Website
ABCL Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ABCL Volatility
AbCellera Biologics Inc. Common Shares has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
